Clinical Trials Directory

Trials / Completed

CompletedNCT05708404

Outpatient Treatment of Severe and Enduring Anorexia Nervosa

A Novel Outpatient Treatment for Patients With Severe and Enduring Anorexia Nervosa: Patient Characteristics, Treatment Goals, and Course of Treatment.

Status
Completed
Phase
Study type
Observational
Enrollment
20 (actual)
Sponsor
Helsinki University Central Hospital · Academic / Other
Sex
Female
Age
18 Years
Healthy volunteers

Summary

Approximately 20-30 % of individuals with the eating disorder anorexia nervosa develop an enduring form of the illness. In this study a new treatment for patients with severe and enduring anorexia nervosa was described. The treatment is flexible and aims at enhancing quality of life. The participants consisted of all referrals resulting in an assessment or treatment period at the unit between May 2017 and May 2022. The study was a registry study. Information regarding patient characteristics, treatment goals, and the course of treatment was gathered from medical records.

Conditions

Interventions

TypeNameDescription
BEHAVIORALOutpatient treatment of severe and enduring anorexia nervosaA novel outpatient treatment of severe and enduring anorexia nervosa, aiming at enhancing quality of life and minimizing harm

Timeline

Start date
2017-05-01
Primary completion
2022-05-31
Completion
2022-05-31
First posted
2023-02-01
Last updated
2023-02-01

Locations

1 site across 1 country: Finland

Source: ClinicalTrials.gov record NCT05708404. Inclusion in this directory is not an endorsement.

Outpatient Treatment of Severe and Enduring Anorexia Nervosa (NCT05708404) · Clinical Trials Directory